À¯·´ÀÇ Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀå : ºÐ¼® ¹× ¿¹Ãø(2023-2033³â)
Europe Rare Disease Genetic Testing Market: Analysis and Forecast, 2023-2033
»óǰÄÚµå : 1452399
¸®¼­Ä¡»ç : BIS Research Inc.
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,950 £Ü 4,268,000
PDF and Excel (1-3 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 3¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,450 £Ü 6,438,000
PDF and Excel (Global License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À¯·´ÀÇ Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀå ±Ô¸ð´Â 2023³â 11¾ï 6,000¸¸ ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 13.60%ÀÇ CAGR·Î 2023³â 41¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀåÀº Èñ±ÍÁúȯÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Èñ±ÍÁúȯÀÇ ¹ß»ý Áõ°¡´Â ÀÌ·¯ÇÑ ¼ºÀå ±Ëµµ¿¡ ¸Å¿ì Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ Àü ¼¼°è ¼Ò¾Æ Àα¸¿¡¼­ Á¶±â ¹ß°ß ¹× ¿¹¹æ¿¡ ´ëÇÑ °ü½ÉÀÌ Áõ°¡Çϰí ÀÖ¾î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯·´ÀÇ Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ÁÖ¿ä µ¿Çâ, ±ÔÁ¦ ȯ°æ, ƯÇã µ¿Çâ, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤±¹°¡º° »ó¼¼ ºÐ¼®, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2023-2033³â
2023³â Æò°¡¾× 11¾ï 6,000¸¸ ´Þ·¯
2033³â Àü¸Á 41¾ï 7,000¸¸ ´Þ·¯
CAGR 13.6%

½ÃÀå ºÐ·ù:

¼¼ºÐÈ­ 1: Áúº´ À¯Çüº°

¼¼ºÐÈ­ 2: ±â¼úº°

¼¼ºÐÈ­ 3: ±¹°¡º°

ÁÖ¿ä ±â¾÷:

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¶»ç ¹üÀ§

Á¦1Àå ½ÃÀå

Á¦2Àå À¯·´

Á¦3Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Introduction to Europe Rare Disease Genetic Testing Market

The Europe rare disease genetic testing market was valued at $1.16 billion in 2023 and is anticipated to reach $4.17 billion by 2033, witnessing a CAGR of 13.60% during the forecast period 2023-2033. The market for genetic testing in rare diseases has experienced notable growth, driven by a rising need for early identification of such conditions. The growing occurrence of rare diseases has been a pivotal factor in this growth trajectory. Moreover, there's a heightened acknowledgment and focus on early detection and prevention, particularly among pediatric populations worldwide, which is anticipated to further drive market growth.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$1.16 Billion
2033 Forecast$4.17 Billion
CAGR13.6%

Market Introduction

The Europe rare disease genetic testing market in Europe is witnessing substantial growth driven by several factors. Increasing awareness and advancements in genetic testing technologies have propelled demand for early detection and diagnosis of rare diseases across the continent. Additionally, the rising prevalence of rare diseases in European populations has contributed significantly to market growth. Moreover, there's a growing emphasis on early intervention and personalized medicine, further boosting the adoption of genetic testing for rare diseases. Regulatory initiatives and healthcare policies promoting accessibility to genetic testing services also play a crucial role in market development. As healthcare systems in Europe prioritize precision medicine and improved patient outcomes, the rare disease genetic testing market is poised for continued growth, offering opportunities for innovation and collaboration among stakeholders in the healthcare sector.

Market Segmentation:

Segmentation 1: by Disease Type

Segmentation 2: by Technology

Segmentation 3: by Country

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The rare disease genetic testing market has been extensively segmented based on various categories, such as disease type, technology, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.

Competitive Strategy: The rare disease genetic testing market has numerous established players paving their way into providing tests, panels, and assays in the market. Key players in the rare disease genetic testing market analyzed and profiled in the study involve established players offering various disease-specific panels and multiplex instruments.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Some of the prominent names established in this market are:

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1 Market

2 Europe

3 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â